Dates: 01/01/2021
31/12/2025
Topic: Biomarkers identification
Project type: Preclinic
Theranostic
Project target: Prostate Cancer
Colorectal Cancer
Financing:
H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC)
Participating agents:
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Keywords: reinforcement; drug resistance; colorectal cancer; prostate cancer; oncology; monotherapy; HTS
Countries: Germany
Project page: Access page